reMYND NV (Privately Held; Biotechnology industry): Chief Scientific Officer, (September 2002-Present) Head of reMYND's drug discovery and development laboratories. Focus on disease-modifying treatments of Alzheimer's and Parkinson's disease. K.U.Leuven (Educational In...
Linkedin
K.U.Leuven (Educational In...